parkinson, Parkinson's research notebook

Six readers

reader	found	score
genetics Open Targets	no genetic evidence; overall 0.02 from other evidence	0.00
cell type Human Protein Atlas	cell type enhanced, including astrocytes; strongest in hepatocytes	0.75
chemistry Open Targets	reachable by antibody	0.45
trials ClinicalTrials.gov	no Parkinson's trials on record: an open field	1.00
literature PubMed	4 Parkinson's papers of 288	0.79
pathways Reactome	1 pathway; mostly other	0.30

No case: the score is under the bar. Receipt 7853

receipt 7861: ITIH4 in dopamine neurons, braak

power: full sample -0.24 (p 0.328, n 18), 95% CI -0.64 to +0.25. the interval is wide: not enough donors to tell.
confounder: adjusted for sex: -0.20 (p 0.434, n 18). does not hold up.
composition: dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.18 (p 0.471, n 18). could be the mix.
skeptic: leave-one-out range -0.37 to -0.13, sign flips 0; without severely affected donors -0.24 (p 0.328, n 18). fragile.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for ITIH4 in dopamine neurons.

case closed: nothing better to follow up.

receipt 7860: ITIH4 in astrocytes, braak

power: full sample -0.52 (p 0.027, n 18), 95% CI -0.79 to -0.07. the interval excludes zero: something may be there, smaller than a half can see.
confounder: adjusted for sex: -0.48 (p 0.042, n 18). holds up.
composition: astrocytes share of nuclei vs axis -0.21 (p 0.413); controlling for it: -0.48 (p 0.044, n 18). not the mix.
skeptic: leave-one-out range -0.65 to -0.46, sign flips 0; without severely affected donors -0.52 (p 0.027, n 18). robust.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for ITIH4 in astrocytes.

case closed: nothing better to follow up.

loading the receipts